Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care...

<OL><LI>This report discusses the impact of care allowances on women care-givers. These programmes, involving some payment for care in informal care settings, have recently been introduced in several OECD Member countries. While their primary goal has been to help older persons in need of care, their...</li></ol>

This study extends research on the impact of age-specific disability trends internationally, with a specific emphasis on long-term care needs. It focuses on changing patterns of disability in populations over 65 for a set of OECD countries for which cross-sectional evidence is available for at...

This paper reviews the performance of French health care system from an economic viewpoint. It also provides some policy recommendations. The health system in France is regarded as delivering high quality services, with freedom of choice and generally no waiting lists for treatments. Access to...

<OL><LI>Policy-makers responsible for publicly-funded drug programmes face continual pressures between the demand to accommodate a steady stream of new and more effective drugs and the ongoing requirement to control costs.</LI> <LI>In the face of these pressures, a growing number of OECD countries are applying...</li></li></ol>

<OL><LI>The Ageing-Related Diseases study compares treatment trends and health outcomes on a disease-by-disease basis. Most of the day-to-day decisions that determine health care system performance are made in treating specific diseases. Therefore, the ARD’s bottom-up approach to comparing health care...</li></ol>

The Ageing-Related Diseases study compares health care systems by examining treatment trends and health outcomes on a disease-by-disease basis. Most of the day-to-day decisions that determine health care system performance are made in treating specific diseases. Therefore, the ARD’s bottom-up...

<OL><LI>This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among three pharmaceutical variables (expenditure,...</li></ol>

This Working Paper analyses the institutional setting for regulatory reform. It is the first comprehensive analysis of regulatory oversight bodies. The analysis adopts a functional approach through four core functions: i) oversight of the rule-making process; ii) assisting rule makers in their...

[fre] Peut-on parler d'une gestion globale de son capital santé ? . En première analyse, les comportements des individus par rapport à leur santé peuvent sembler assez cohérents : les consommateurs d'alcool ou de tabac surveillent moins leur poids ou leur alimentation, ont moins recours aux...